Olink (RUO, plasma)

Proteomics analysis of blood plasma that maps proteins to help identify biomarkers and inform treatment thinking.

Vetted listing

Testing

Consented intake · your records travel with you · nothing moves without your sign-off

Why Olink exists

Olink offers proteomics, the mapping and analysis of proteins, using plasma as input. The approach models the signature pathways of cancer cells to identify biomarkers that may inform treatment. Olink's offering is for research use only, which matters for patients deciding now: it can add insight, but it is not a clinical diagnostic service.

Part of Thermo Fisher ScientificService network · More than 75 certified service providers

1
Immuno reaction
Two matched antibodies labeled with unique DNA oligonucleotides bind to a target protein in solution.
2
Extension
Once in proximity, the DNA oligos hybridize and are extended by DNA polymerase, creating a DNA barcode unique to each protein.
3
Detection
The DNA barcode is amplified by PCR, generating a signal that is measured by next generation sequencing or qPCR.

Prefer the source? Olink (RUO, plasma)'s own site has more.

Share your records

We'll pre-fill the intake from your records — no retyping.

Start sharing →

Check your coverage

See if your insurance covers this and estimate out-of-pocket cost.

Check coverage →

Coverage, insurance & cost

The fastest way to know what you'll pay: check your coverage with your plan. Below is what we know about how Olink (RUO, plasma) handles billing.

We don't have confirmed insurance details for Olink (RUO, plasma) yet. Start a coverage check with your plan, or contact the provider directly.

Common questions about Olink

How does Olink work?

1. Immuno reaction — Two matched antibodies labeled with unique DNA oligonucleotides bind to a target protein in solution. 2. Extension — Once in proximity, the DNA oligos hybridize and are extended by DNA polymerase, creating a DNA barcode unique to each protein. 3. Detection — The DNA barcode is amplified by PCR, generating a signal that is measured by next generation sequencing or qPCR.

How do I connect with Olink?

Through OpenCancer's consented intake: enter your details once, choose exactly which records travel with the request, and sign a consent that covers this connection only. Nothing is shared without your sign-off.

Ask about this service

Answers grounded in Olink's details here. Educational only; your oncologist directs treatment.

Also consider

Other providers in similar categories.

BostonGene

6 offerings

Gather distinctive biomarkers that can guide treatment and monitor disease progression

Foundation Medicine

6 offerings

FoundationOne CDx is an FDA-approved comprehensive genomic profiling test that analyzes 324 genes to identify clinically relevant genomic alterations.